Navigation Links
Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
Date:9/21/2010

COLUMBUS, Ohio and HAYWARD, Calif., Sept. 21 /PRNewswire/ -- Oxford Resource Partners, LP (NYSE: OXF) ("Oxford") and Mendel Biotechnology, Inc. ("Mendel") today announced their collaborative agreement to develop a pilot project to produce Mendel's proprietary Miscanthus varieties on land previously reclaimed from mining operations by Oxford. The goal of the project is to demonstrate the feasibility and economic viability of biomass production from dedicated energy crops in eastern Ohio.

Miscanthus is a genus of high-yielding perennial grass that has shown great promise as a sustainable source of renewable energy. Its deep rhizome structure and broad adaptation make it a potentially attractive crop for converting reclaimed mine land to a source of biomass for electricity or liquid transportation fuel.

"While Oxford's focus will always be responsible coal mining, we recognize that utilities in the State of Ohio are committed to including biomass among their fuel sources in the coming years," said Charles C. Ungurean, President and CEO of Oxford. "Part of our responsibility is to reclaim land that was formerly mined, a program in which we take great pride. As such, we are pleased to be able to assist our utility partners in advancing their efforts to develop alternative fuel sources," continued Mr. Ungurean.

"We are excited to work with Oxford to demonstrate Miscanthus as a viable option for this important energy producing region of the country," said Neal Gutterson, Mendel's President and CEO. "The goal of energy independence provides the spark for innovative companies such as Oxford to find ways to convert marginal or otherwise idle lands to a more sustainable use by employing the latest advancements in genetics and crop technologies."

About Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam co
'/>"/>

SOURCE Oxford Resource Partners, LP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
2. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
3. Oxford BioTherapeutics Appoints Michael Moore as Chairman
4. Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
5. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
6. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
7. Bavarian Nordics Case Against Oxford BioMedica
8. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
9. New resource examines questions about the role of nanoscience
10. Web Resource for Interferon Research
11. Gramene Announces Scholarships for Groups Underrepresented in Science to Learn How to Use Bioinformatics and Genomics Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015   Synageva BioPharma Corp. ... company developing therapeutic products for rare disorders, today ... 2015 goals, other key objectives, and financial guidance.  ... today at 4:30 p.m. EST to review the ... To participate in today,s call by telephone, please ...
(Date:2/26/2015)... Woodbridge, NJ (PRWEB) February 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... in a trade secrets lawsuit against Genewiz Inc. in ... illegally obtained and utilized GenScript’s trade secrets, and that ... The court entered an order denying motions for ...
(Date:2/26/2015)... Already well respected for accuracy, HEIDENHAIN now ... Length Gauge offerings with new variants of its successful ... HEIDENHAIN’s pencil probe-style SPECTO length gauge series now offers ... 1Vpp, 12mm stroke length variants of the SPECTO series ... variant with a weak spring, 0.4N of gauging force, ...
(Date:2/26/2015)... Regis Technologies announced new potent ... drug substances. , Regis Technologies is proud to announce ... Compound Suite (PCS) for 2015. , Regis is a ... facility in Morton Grove, Illinois. The PCS addition will ... up to about one kilogram per batch. , ...
Breaking Biology Technology:Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2Regis Extends cGMP Services to Oncology Market 2
... and CLAREMONT, Calif., Aug. 11 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech ... for the second quarter of 2008 ended June ... of $1,872,647 for the second,quarter of 2007. Revenues ... of 60% from the previous year., The ...
... TELK ) reported a net loss of $13.6 million, ... 2008, compared with a net loss of,$14.3 million, or $0.27 ... net loss for the second quarter ended June 30, 2008, ... which,is reflected in interest and other income (expense)., For ...
... of at least half of shipments by the ... GlaxoSmithKline (NYSE:,GSK) today announced that it will begin ... Virus Vaccine] to U.S. customers,for the 2008-2009 influenza ... for Biologics Evaluation and Research (CBER) released the,first ...
Cached Biology Technology:Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million 2Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million 3Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million 4Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million 5Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million 6Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million 7Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million 8Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million 9Telik Announces Financial Results For 2008 Second Quarter 2Telik Announces Financial Results For 2008 Second Quarter 3Telik Announces Financial Results For 2008 Second Quarter 4GSK Begins Shipments of Fluarix(R) and FluLaval(R) to U.S. Customers for 2008-2009 Influenza Season 2GSK Begins Shipments of Fluarix(R) and FluLaval(R) to U.S. Customers for 2008-2009 Influenza Season 3GSK Begins Shipments of Fluarix(R) and FluLaval(R) to U.S. Customers for 2008-2009 Influenza Season 4
(Date:2/24/2015)... , Feb. 24, 2015 Research and ... the addition of the "Global 2D Gesture ... The analysts forecast the Global ... CAGR of 32.12% over the period 2014-2019 ... in non-traditional sectors is one of the major ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT Genomics ... that aims to transform cancer genomic information into ... the company has raised US$ 8 million in the ... in Taipei, Taiwan , ACT ... ACTOnco™. With the aim to implement next generation ...
(Date:2/10/2015)... -- Alere Inc. (NYSE: ALR), a global leader in ... quarter ended December 31, 2014. Namal ... said, "We made substantial progress in the fourth ... in rapid diagnostics and delivering against our financial ... early January enabled us to substantially reduce our ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34
... is available in German . , Castor oil ... used in ancient times with pregnant women to induce labour. Only ... Lung Research succeeded in unravelling the mysteries of the action mechanism. ... the intestine and uterus is apparently responsible. This is activated by ...
... University are working with the U.S. Army and neurosurgeons ... a new type of "bioactive" coating for stents used to ... bomb blasts. "Stents coated with a bioactive coating might ... heal the inside lining of the blood vessel," said Jean ...
... harmful mercury in plants and animals, a new study by ... has compared levels of the chemical in captive dolphins with ... a controlled diet, while the wild mammals dined on marine ... study found lower levels of mercury in the captive animals, ...
Cached Biology News:G protein-coupled receptor mediates the action of castor oil 2G protein-coupled receptor mediates the action of castor oil 3Purdue professor to speak before Congress about nanotechnology in brain treatment research 2Purdue professor to speak before Congress about nanotechnology in brain treatment research 3Mercury in dolphins: Study compares toxin levels in captive and wild sea mammals 2Mercury in dolphins: Study compares toxin levels in captive and wild sea mammals 3
Rabbit polyclonal to Streptococcus Enterotoxin C ( Abpromise for all tested applications)....
... Cultured human omental ... obese but otherwise healthy ... availability of diabetic cells. ... information. Support media also ...
Anti-Flavocytochrome b Monoclonal, FITC Labeled Research Focus: other Storage: 4C Shipping Temperature: 4C...
Yields DNA greater than 50 kb in length from yeast, fungi, Gram neg. and Gram pos. bacteria...
Biology Products: